Researchers have successfully synthesized folate-modified exosome-liposome hybrid nanoparticles loaded with ALKBH5 mRNA, which showed significant inhibition of colorectal cancer progression in tumor models by modulating the ALKBH5/JMJD8/PKM2 axis and hampering glycolysis [116]. Here, ALKBH5 is linked to colorectal cancer.